NASDAQ
1.53USD
+0.04 (+2.68%)
We have scored 5 news catalysts on MindWalk Holdings Corp. (HYFT) over the past 12 months. The biggest single-day move next to one of them came Jul 23, 2026, when HYFT closed −18.1%: “MindWalk Holdings Corp. (HYFT) Reports Q4 Loss, Misses Revenue Estimates”. Coverage across the window leans negative (average ticker sentiment −0.12). Most of the impact sits in price momentum and earnings surprise volatility.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
73.3M
P/E
—
EPS
—
Beta
0.83
52W range
0.99-2.99
Day range
1.51–1.79
Open
1.56
Prev close
1.49
Volume
1.3M
Avg volume
273K
Dividend
0.00
IPO
2002-01-07
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about MindWalk Holdings Corp. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for HYFT: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
